Substance
ROMIPLOSTIM
Global reference: every product and company linked to this substance.
- cas: 267639-76-9
- ncit: C52183
- pubchem_cid: 66583167
- rxnorm: 805452
- unii: GN5XU2DXKV
AMG 531 · NPLATE · ROMIPLATE · romiplostim [INN] · ROMIPLOSTIM [JAN] · ROMIPLOSTIM [USAN] · Romiplostim [WHO-DD]
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| AMGEN INC. COMMON STOCK | NPLATE | Q2 2026 | $430.0M |
| AMGEN INC. COMMON STOCK | NPLATE | Q2 2026 | $430.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- NPLATE · AMGEN INC. COMMON STOCK
- NPLATE · AMGEN INC. COMMON STOCK